How Weekly Vitamin Treatment Affects Thinking in Kidney Patients on Dialysis
Phase 2
- Conditions
- Health Condition 1: N184- Chronic kidney disease, stage 4 (severe)
- Registration Number
- CTRI/2024/07/070810
- Lead Sponsor
- Meitra Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients above 18 years
2.On MHD for CKD for more than three months
3.Patients who agree to give consent for the study
Exclusion Criteria
1.Patients with diagnosed dementia like
Alzheimer’s.
2.Patients with malignancy.
3.Patients who are unable to cooperate and
complete study.
4.Patients allergic to thiamine.
5.Patients who are already on thiamine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is the cognitive assessment with MOCA at the end of 24 weeksTimepoint: The primary endpoint is the cognitive assessment with MOCA at the end of 24 weeks
- Secondary Outcome Measures
Name Time Method 1.The number of hospital admission days in the treatment and control groups at 24 weeks. <br/ ><br>2.Survival comparison between the treatment and control groups at 24 weeks of follow-up. <br/ ><br>3.The Quality of life in both groups at baseline and after 24 weeks <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 24 weeks